Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
Canada Royal Enoch Phytomedicine announced a clinical trial to examine the efficacy of its product, Redsenol-1 Plus Noble Ginsenoside Capsules, for treating cancer-related fatigue. The trial will be conducted by KGK Science.
read more
The U.S. Food and Drug Administration (FDA) has approved a label update for Rybelsus® (semaglutide) tablets 7 mg or 14 mg, allowing use as a first-line treatment option for adults with type 2 diabetes who have not previously taken a diabetes treatment.
read more
The global prescription drug market is estimated to increase at a CAGR of 4.98%, from $969.3B in 2020 to $1,36T by the end of 2027.
read more
Ascletis Pharma announces that its wholly owned subsidiary Ascletis Pharmaceuticals has entered into a supply agreement of ritonavir tablets with Hainan Simcere Pharmaceutical Co., a subsidiary of Simcere Pharmaceutical Group Limited.
read more
Lonza announces the completion of a planned expansion to its Solid Form Services (SFS) offering for small molecule drugs.
read more
Cambrex, a contract development and manufacturing organization (CDMO), announced that it has completed its acquisition of Snapdragon Chemistry, a US-based provider of chemical process development services to a broad range of emerging and established biopharma customers.
read more
The global microcrystalline cellulose market is anticipated to witness robust growth in the forecast period, 2024-2028, according to a report from Research & Markets.
read more
The pharmacy automation market size is estimated to be $5.5B in 2022 and is expected to witness a CAGR of 10.26% during the forecast period 2023-2033, according to a report from Research & Markets.
read more
The U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Jardiance® (empagliflozin) tablets, which is being investigated as a potential treatment to reduce the risk of kidney disease progression and cardiovascular death in adults with chronic kidney disease (CKD), Boehringer Ingelheim and Eli Lilly and...
read more
The global antibiotics market size reached $47.4B in 2021, according to a report from Research & Markets. The report projects that the market will reach $61.5B by 2027, exhibiting a CAGR of 4.44% during 2021-2027.
read more
The global pharmaceutical packaging equipment market is expected to reach $8.69B by 2030, expanding at 5.5% CAGR from 2023 to 2030, according to a report by Grand View Research.
read more
TheracosBio announced that the U.S. Food and Drug Administration (FDA) has approved Brenzavvy™ (bexagliflozin), an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor.
read more
ACG, supplier of pharmaceutical and nutraceutical manufacturing products, announced the appointment of Rafael Costa as Vice President for the Americas region.
read more
The global nutraceutical excipients market is expected to reach the value of $3,685.86M by 2030, at a CAGR of 7.4% during the forecast period, according to a report from Data Bridge Market Research.
read more
The global rheumatoid arthritis drugs market is estimated to grow annually at a CAGR of around 1.75% over the forecast period (2022-2030). In terms of revenue, the global rheumatoid arthritis drugs market size was valued at around $60.1B in 2021 and is projected to reach $70.1B by 2030, according to a report by Facts and Factors.
read more